(Treffer aus TechnoPharm, Nr. 06, Seite 320 (2016))
Single-use Mini Scale Bioreactor Technology / How it Enables Higher Productivity of Protein-based Therapeutics in the Pharmaceutical Industry · Ngibuini M · Sartorius Stedim Biotech, Royston (UK)
Development of expensive to manufacture biologics continues growing worldwide, with pipelines including monoclonal antibodies and novel scaffold approaches to engineer therapeutic proteins. As a result, finding more cost-effective and efficient methods of improving upstream production of cell culture and microbial fermentation is a high priority for many biopharmaceutical firms.